Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice.
Guidelines
Multidisciplinary tumor board
Thoracic malignancies
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
19
04
2023
accepted:
26
06
2023
medline:
31
8
2023
pubmed:
5
7
2023
entrez:
4
7
2023
Statut:
ppublish
Résumé
Evaluating patients and treatment decisions in a multidisciplinary tumor board has led to better quality of care and longer survival in cancer patients. The aim of this study was to evaluate tumor board recommendations for thoracic oncology patients regarding guideline adherence and transferal of recommendations into clinical practice. We evaluated tumor board recommendations of the thoracic oncology tumor board at Ludwig-Maximilians University (LMU) Hospital Munich between 2014 and 2016. We compared patient characteristics between guideline-adherent and non-guideline-adherent recommendations, as well as between transferred and non-transferred recommendations. We used multivariate logistic regression models to evaluate factors associated with guideline adherence. Over 90% of recommendations by the tumor board were either adherent to the guidelines (75.5%) or over fulfilling guidelines (15.6%). Almost 90% of recommendations were transferred to clinical practice. If a recommendation was not according to the guidelines, the reason was mostly associated with the general condition (age, Charlson comorbidity index, ECOG) of the patient or due to the patients' request. Surprisingly, sex also had a significant influence on the guideline adherence of recommendations, with females being more likely to get recommendations not according to the guidelines. In conclusion, the results of this study are promising, as the guideline adherence of recommendations as well as the transferal of recommendations into clinical practice were high. In the future, a special focus should be put on fragile patients as well as female patients.
Identifiants
pubmed: 37402967
doi: 10.1007/s00432-023-05025-1
pii: 10.1007/s00432-023-05025-1
pmc: PMC10465379
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11679-11688Informations de copyright
© 2023. The Author(s).
Références
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Lung Cancer. 2021 Feb;152:149-156
pubmed: 33418430
BMC Health Serv Res. 2020 Jan 31;20(1):73
pubmed: 32005232
J Oncol Pract. 2010 Nov;6(6):e17-20
pubmed: 21358945
Intern Med J. 2009 Dec;39(12):838-41
pubmed: 20233244
Lung Cancer. 2012 Feb;75(2):255-60
pubmed: 21816502
JCO Precis Oncol. 2020 Nov;4:393-410
pubmed: 35050740
JAMA Netw Open. 2021 Jun 1;4(6):e2113749
pubmed: 34143192
Pneumologie. 2010 Mar;64 Suppl 2:e1-164
pubmed: 20217630
J Am Coll Surg. 2013 Sep;217(3):412-20
pubmed: 23891067
Contemp Clin Trials. 2022 Apr;115:106718
pubmed: 35247632
Cancer Imaging. 2011 Oct 03;11 Spec No A:S79-84
pubmed: 22185865